SEARCH RESULTS for assignee:"janssen biotech"

Showing 1 to 20 of 24 results

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
28-May-2018

(X0) 1: Bispecific EGFR/C-Met Antibodies

(A1) 2: Bispecific EGFR/C-Met Antibodies

CHIU, MARK

MOORES, SHERI

NEIJSSEN, JOOST

PARREN, PAUL

SCHUURMAN, JANINE

JANSSEN BIOTECH, INC.

45902/821

23-May-2018

(X0) 1: Methods and Compositions for Cell Attachment and Cultivation on Planar Substrates

(A1) 2: Methods and Compositions for Cell Attachment and Cultivation on Planar Substrates

(B2) 9: Methods and Compositions for Cell Attachment and Cultivation on Planar Substrates

JANSSEN BIOTECH, INC.

45869/103

15-May-2018

(X0) 1: Pluripotent Stem Cell Culture on Micro-Carriers

(A1) 2: Pluripotent Stem Cell Culture on Micro-Carriers

(B2) 9: Pluripotent Stem Cell Culture on Micro-Carriers

JANSSEN BIOTECH, INC.

35090/703

15-May-2018

JANSSEN BIOTECH, INC.

41332/881

30-Apr-2018

(X0) 1: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

(A1) 2: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

AHMADI, TAHAMTAN

SASSER, AMY

CASNEUF, TINEKE

LOKHORST, HENK

MUTIS, TUNA

VAN DE DONK, NIELS

JANSSEN BIOTECH, INC.

45662/229

06-Apr-2018

(X0) 1: METHODS FOR PREPARATION OF QUINAZOLINE DERIVATIVES

(A1) 2: METHODS FOR PREPARATION OF QUINAZOLINE DERIVATIVES

MANI, NEELAKANDHA S.

ALLISON, BRETT D.

SALES, ZACHARY S.

LIANG, JIMMY T.

JANSSEN BIOTECH, INC.

45451/982

05-Apr-2018

(X0) 1: ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES

(A1) 2: ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES

WU, SHENG-JIUN

FERRANTE, CATHERINE

UBANI, ENRIQUE ZUDAIRE

JANSSEN BIOTECH, INC.

45433/927

30-Mar-2018

(X0) 1: ANTI-ROR1, ANTIBODIES, ROR1 X CD3 BISPECIFIC ANTIBODIES, AND METHODS OF USING THE SAME

(A1) 2: ANTI-ROR1, ANTIBODIES, ROR1 X CD3 BISPECIFIC ANTIBODIES, AND METHODS OF USING THE SAME

ANDERSON, GLENN MARK

BALDWIN, ERIC T.

HARMAN, BENJAMIN

CARDOSO, ROSA M.F.

NEMETH-SEAY, JENNIFER F.

ATTAR, RICARDO

GAUDET, FRANCOIS

LI, YINGZHE

LUO, JINQUAN

MCDAID, RONAN

POMERANTZ, STEVEN C.

TAM, SUSAN H.

TEPLYAKOV, ALEXEY

WU, SHENG-JIUN

JANSSEN BIOTECH, INC.

45385/728

28-Mar-2018

(X0) 1: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

(A1) 2: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

AHMADI, TAHAMTAN

CASNEUF, TINEKE

LOKHORST, HENK

MUTIS, TUNA

SASSER, AMY

VAN DE DONK, NIELS

JANSSEN BIOTECH, INC.

45356/222

27-Mar-2018

ETHICON LLC

ETHICON ENDO-SURGERY, INC.

JANSSEN RESEARCH & DEVELOPMENT, LLC

JANSSEN BIOTECH, INC.

41354/489

27-Mar-2018

(X0) 1: Methods of Reducing Clinical Symptoms of Viral Infection by Administering a Toll-Like Receptor 3 Antagonist

(A1) 2: Methods of Reducing Clinical Symptoms of Viral Infection by Administering a Toll-Like Receptor 3 Antagonist

(B2) 9: Methods of Reducing Clinical Symptoms of Viral Infection by Administering a Toll-Like Receptor 3 Antagonist

JANSSEN BIOTECH, INC.

45346/744

27-Feb-2018

(X0) 1: INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS

(A1) 2: INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS

(B2) 9: INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS

CHI, ELLEN

CONNOR, JUDITH

LIN-SCHMIDT, XIEFAN

MARTINEZ, CHRISTIAN

SWANSON, RONALD

HUANG, CHICHI

JORDAN, JARRAT

LUO, JINQUAN

LU, LU

OBMOLOVA, GALINA

JANSSEN BIOTECH, INC.

33232/964

15-Feb-2018

(X0) 1: Engineered Antibodies and Other FC-Domain Containing Molecules with Enhanced Agonism and Effector Functions

(A1) 2: Engineered Antibodies and Other FC-Domain Containing Molecules with Enhanced Agonism and Effector Functions

ARMSTRONG, ANTHONY

CHIU, MARK

ZHANG, DI

JANSSEN BIOTECH, INC.

43982/729

13-Feb-2018

(X0) 1: MEDIA SUCTION DEVICES AND METHODS

(A1) 2: MEDIA SUCTION DEVICES AND METHODS

(B2) 9: MEDIA SUCTION DEVICES AND METHODS

LANIAUSKAS, DAINA

HAMMER, JOSEPH

JANSSEN BIOTECH, INC.

32406/181

13-Feb-2018

(X0) 1: CELL ENCAPSULATION LOADING DEVICE

(A1) 2: CELL ENCAPSULATION LOADING DEVICE

(B2) 9: CELL ENCAPSULATION LOADING DEVICE

EVANS, STEPHEN

BELL, AUDREY

JANSSEN BIOTECH, INC.

37768/612

12-Feb-2018

(X0) 1: Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors

(A1) 2: Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors

DOSHI, PARUL

LOKHORST, HENK

MUTIS, TUNA

JANSSEN BIOTECH, INC.

44878/829

08-Feb-2018

(X0) 1: COMBINATION TREATMENT FOR HEMATOLOGICAL CANCERS

(A1) 2: COMBINATION TREATMENT FOR HEMATOLOGICAL CANCERS

HUANG, FEI

RUSBULDT, JOSHUA J.

RIZO, ALEKSANDRA

JANSSEN BIOTECH, INC.

43817/246

18-Jan-2018

(X0) 1: TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS

(A1) 2: TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS

JANSSEN BIOTECH, INC.

44584/269

18-Jan-2018

(X0) 1: TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS

(A1) 2: TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS

JANSSEN BIOTECH, INC.

44584/358

18-Jan-2018

(X0) 1: APPARATUS AND METHOD TO FORM ENTRY BLEB FOR SUBRETINAL DELIVERY OF THERAPEUTIC AGENT

(A1) 2: APPARATUS AND METHOD TO FORM ENTRY BLEB FOR SUBRETINAL DELIVERY OF THERAPEUTIC AGENT

JANSSEN BIOTECH, INC.

44636/622